Eastman Chemical (EMN)
(Real Time Quote from BATS)
$95.18 USD
-1.18 (-1.23%)
Updated Apr 25, 2024 11:04 AM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Eastman Chemical (EMN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$100.59 | $121.00 | $78.00 | 4.39% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Eastman Chemical comes to $100.59. The forecasts range from a low of $78.00 to a high of $121.00. The average price target represents an increase of 4.39% from the last closing price of $96.36.
Analyst Price Targets (17)
Broker Rating
Eastman Chemical currently has an average brokerage recommendation (ABR) of 2.09 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 2.09 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 41.18% and 5.88% of all recommendations. A month ago, Strong Buy made up 41.18%, while Buy represented 5.88%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 9 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.09 | 2.09 | 2.09 | 2.09 | 2.16 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
12/15/2023 | Tudor Pickering Holt & Co. | Matthew Blair | Not Available | Strong Buy |
11/28/2023 | Mizuho SecuritiesUSA | John Roberts | Not Available | Hold |
10/11/2023 | Piper Sandler | Charles N Neivert | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.09 |
ABR (Last week) | 2.09 |
# of Recs in ABR | 17 |
Average Target Price | $100.59 |
LT Growth Rate | 11.70% |
Industry | Chemical - Diversified |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | 1.41 |